112 related articles for article (PubMed ID: 16432877)
1. A topological substructural approach for the prediction of P-glycoprotein substrates.
Cabrera MA; González I; Fernández C; Navarro C; Bermejo M
J Pharm Sci; 2006 Mar; 95(3):589-606. PubMed ID: 16432877
[TBL] [Abstract][Full Text] [Related]
2. TOPS-MODE approach for the prediction of blood-brain barrier permeation.
Cabrera MA; Bermejo M; Pérez M; Ramos R
J Pharm Sci; 2004 Jul; 93(7):1701-17. PubMed ID: 15176060
[TBL] [Abstract][Full Text] [Related]
3. A topological substructural approach applied to the computational prediction of rodent carcinogenicity.
Helguera AM; Cabrera Pérez MA; González MP; Ruiz RM; González Díaz H
Bioorg Med Chem; 2005 Apr; 13(7):2477-88. PubMed ID: 15755650
[TBL] [Abstract][Full Text] [Related]
4. In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS-MODE approach.
Cabrera Pérez MA; Sanz MB
Bioorg Med Chem; 2004 Nov; 12(22):5833-43. PubMed ID: 15498659
[TBL] [Abstract][Full Text] [Related]
5. Prediction of P-glycoprotein substrates by a support vector machine approach.
Xue Y; Yap CW; Sun LZ; Cao ZW; Wang JF; Chen YZ
J Chem Inf Comput Sci; 2004; 44(4):1497-505. PubMed ID: 15272858
[TBL] [Abstract][Full Text] [Related]
6. Structural contributions of substrates to their binding to P-Glycoprotein. A TOPS-MODE approach.
Estrada E; Molina E; Nodarse D; Uriarte E
Curr Pharm Des; 2010; 16(24):2676-709. PubMed ID: 20642431
[TBL] [Abstract][Full Text] [Related]
7. ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates.
Li D; Chen L; Li Y; Tian S; Sun H; Hou T
Mol Pharm; 2014 Mar; 11(3):716-26. PubMed ID: 24499501
[TBL] [Abstract][Full Text] [Related]
8. Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model.
Gombar VK; Polli JW; Humphreys JE; Wring SA; Serabjit-Singh CS
J Pharm Sci; 2004 Apr; 93(4):957-68. PubMed ID: 14999732
[TBL] [Abstract][Full Text] [Related]
9. A topological sub-structural approach for predicting human intestinal absorption of drugs.
Pérez MA; Sanz MB; Torres LR; Avalos RG; González MP; Díaz HG
Eur J Med Chem; 2004 Nov; 39(11):905-16. PubMed ID: 15501539
[TBL] [Abstract][Full Text] [Related]
10. Integration of in silico and in vitro tools for scaffold optimization during drug discovery: predicting P-glycoprotein efflux.
Desai PV; Sawada GA; Watson IA; Raub TJ
Mol Pharm; 2013 Apr; 10(4):1249-61. PubMed ID: 23363443
[TBL] [Abstract][Full Text] [Related]
11. Predicting carcinogenicity and understanding the carcinogenic mechanism of N-nitroso compounds using a TOPS-MODE approach.
Yuan J; Pu Y; Yin L
Chem Res Toxicol; 2011 Dec; 24(12):2269-79. PubMed ID: 22084901
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein substrate models using support vector machines based on a comprehensive data set.
Wang Z; Chen Y; Liang H; Bender A; Glen RC; Yan A
J Chem Inf Model; 2011 Jun; 51(6):1447-56. PubMed ID: 21604677
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial QSAR modeling of P-glycoprotein substrates.
de Cerqueira Lima P; Golbraikh A; Oloff S; Xiao Y; Tropsha A
J Chem Inf Model; 2006; 46(3):1245-54. PubMed ID: 16711744
[TBL] [Abstract][Full Text] [Related]
14. Identifying P-glycoprotein substrates using a support vector machine optimized by a particle swarm.
Huang J; Ma G; Muhammad I; Cheng Y
J Chem Inf Model; 2007; 47(4):1638-47. PubMed ID: 17608407
[TBL] [Abstract][Full Text] [Related]
15. Development of in Silico Models for Predicting P-Glycoprotein Inhibitors Based on a Two-Step Approach for Feature Selection and Its Application to Chinese Herbal Medicine Screening.
Yang M; Chen J; Shi X; Xu L; Xi Z; You L; An R; Wang X
Mol Pharm; 2015 Oct; 12(10):3691-713. PubMed ID: 26376206
[TBL] [Abstract][Full Text] [Related]
16. Computational models for identifying potential P-glycoprotein substrates and inhibitors.
Crivori P; Reinach B; Pezzetta D; Poggesi I
Mol Pharm; 2006; 3(1):33-44. PubMed ID: 16686367
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to predict a toxicological property of aromatic compounds in the Tetrahymena pyriformis.
González MP; Díaz HG; Cabrera MA; Ruiz RM
Bioorg Med Chem; 2004 Feb; 12(4):735-44. PubMed ID: 14759733
[TBL] [Abstract][Full Text] [Related]
18. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
Varma MV; Sateesh K; Panchagnula R
Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
[TBL] [Abstract][Full Text] [Related]
19. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
20. Development of an in silico model for predicting efflux substrates in Caco-2 cells.
Zhang L; Balimane PV; Johnson SR; Chong S
Int J Pharm; 2007 Oct; 343(1-2):98-105. PubMed ID: 17583455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
